A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
Titel:
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
Auteur:
Kelly, R.J. Thomas, A. Rajan, A. Chun, G. Lopez-Chavez, A. Szabo, E. Spencer, S. Carter, C.A. Guha, U. Khozin, S. Poondru, S. Van Sant, C. Keating, A. Steinberg, S.M. Figg, W. Giaccone, G.